Intra-Cellular Therapies Inc
ITCI · NASDAQ
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.
ESG Scores
Overall ESG5.9
Environmental2.9
Social3.1
Governance5.8
Gender Diversity
Female Directors0.16670000000000001%
Female Executives0.47008547008547014%
CEO GenderFemale